Compare DTIL & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DTIL | PETS |
|---|---|---|
| Founded | 2006 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail-Drug Stores and Proprietary Stores |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 97.7M | 61.6M |
| IPO Year | 2019 | 2003 |
| Metric | DTIL | PETS |
|---|---|---|
| Price | $5.32 | $2.58 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 1 | 1 |
| Target Price | ★ $60.00 | $3.20 |
| AVG Volume (30 Days) | ★ 158.4K | 135.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 106.52 | 18.92 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,070,000,000.00 | $273,800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $34.30 | $2.98 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.53 | $1.57 |
| 52 Week High | $8.82 | $4.32 |
| Indicator | DTIL | PETS |
|---|---|---|
| Relative Strength Index (RSI) | 72.90 | 31.15 |
| Support Level | $5.29 | $2.44 |
| Resistance Level | $5.67 | $2.93 |
| Average True Range (ATR) | 0.30 | 0.11 |
| MACD | 0.13 | -0.02 |
| Stochastic Oscillator | 91.53 | 8.93 |
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.